Signal Explorer

Warrant Valued Black Scholes Ipo Net Proceeds Disclosure New York Jurisdiction Clause Fcpa Compliance Representation Corporate Authority Representation Market Price Definition Change Of Control Definition Nyse Listing Disclosure Amendment Modification Waiver Clause Form S3 Shelf Registration Disclosure Warrant Exercise Share Delivery Auditor Appointment Ratification Legal Opinion Methodology Disclosure Corporate Organization And Standing Representation Fractional Share Cash Payment

Regulatory Designation Only Clinical Trial Result Indication Expansion Lead Asset Progress Combination Therapy Mentioned Clinical Hold

Fast Track Designation Received Fast Track Granted Orphan Status Granted Patient Retention High Enrollment Ahead Of Schedule Interim Data Positive Forward Looking Statement Definition

Orphan Drug Designation Clinical Hold Active

Capital Raising Uncertainty Disclosed Liquidity Position Snapshot Disclosed Net Loss Reported Operating Lease Rent Expense Disclosed Quarterly Tax Provision Benefit Disclosure Material Weakness Internal Controls Cash Flow Statement Investing Activities Enrollment Ahead Of Schedule Financing Activities Cash Flow Disclosure Depreciation Expense Composition Disclosure Shares Outstanding Disclosure Valuation Allowance Deferred Tax Disclosure No Icfr Changes In Quarter Acquisition And Management Fees Disclosed

Indication Expansion

Regulatory Designation Only Clinical Trial Result Lead Asset Progress Combination Therapy Mentioned Indication Expansion

Fast Track Designation Received Net Loss Reported Fast Track Granted Orphan Status Granted Administrative Efficiency Interim Data Positive Burn Rate Controlled Personnel Cost Decrease Disclosure Enrollment Ahead Of Schedule

Orphan Drug Designation

Auditor Appointment Ratification Classified Board Director Election

Net Loss Reported Depreciation Expense Composition Disclosure Segment Aggregation Disclosure Orphan Status Granted Liquidity Position Snapshot Disclosed Fast Track Granted Fast Track Designation Received Cash Flow Statement Investing Activities Fair Value Hierarchy Disclosure Breakthrough Therapy Granted Valuation Allowance Deferred Tax Disclosure Shares Outstanding Disclosure

Regulatory Designation Only Indication Expansion

Orphan Drug Designation

Net Loss Reported Fast Track Designation Received Fast Track Granted Administrative Efficiency Orphan Status Granted Publication Positive Enrollment Ahead Of Schedule Personnel Cost Decrease Disclosure Interim Data Positive

Regulatory Designation Only Clinical Trial Result Combination Therapy Mentioned Lead Asset Progress Indication Expansion

Orphan Drug Designation